BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15934082)

  • 1. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome.
    Barone F; Bombardieri M; Manzo A; Blades MC; Morgan PR; Challacombe SJ; Valesini G; Pitzalis C
    Arthritis Rheum; 2005 Jun; 52(6):1773-84. PubMed ID: 15934082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
    Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C
    J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.
    Manzo A; Paoletti S; Carulli M; Blades MC; Barone F; Yanni G; Fitzgerald O; Bresnihan B; Caporali R; Montecucco C; Uguccioni M; Pitzalis C
    Eur J Immunol; 2005 May; 35(5):1347-59. PubMed ID: 15832291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome.
    Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M
    Scand J Immunol; 2002 Apr; 55(4):336-42. PubMed ID: 11967114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis.
    Bombardieri M; Pitzalis C
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1989-96. PubMed ID: 22208651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
    Salomonsson S; Jonsson MV; Skarstein K; Brokstad KA; Hjelmström P; Wahren-Herlenius M; Jonsson R
    Arthritis Rheum; 2003 Nov; 48(11):3187-201. PubMed ID: 14613282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren's syndrome.
    Lee KE; Kang JH; Yim YR; Kim JE; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Yoon KC; Lee JS; Lee SS
    Clin Exp Rheumatol; 2017; 35(2):234-240. PubMed ID: 27782867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
    Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
    Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CXC chemokine ligand 13, CC chemokine ligand (CCL) 19, and CCL21 in the organization and function of nasal-associated lymphoid tissue.
    Rangel-Moreno J; Moyron-Quiroz J; Kusser K; Hartson L; Nakano H; Randall TD
    J Immunol; 2005 Oct; 175(8):4904-13. PubMed ID: 16210592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
    Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
    Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome.
    Prochorec-Sobieszek M; Wagner T; Loukas M; Chwalińska-Sadowska H; Olesińska M
    Med Sci Monit; 2004 Apr; 10(4):BR115-21. PubMed ID: 15039641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.
    Nandula SR; Scindia YM; Dey P; Bagavant H; Deshmukh US
    Oral Dis; 2011 Nov; 17(8):801-7. PubMed ID: 21815968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
    Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
    Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
    Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.